Attrecto provides professional development and consulting services specialized for web technologies for major firms in Hungary and for clients in Europe and America (e.g. global IT, telecom, and insurance firms). The company, founded in 2009, has a staff of over 60 and has cooperated with such companies as Telenor (Norway), Sasktel (Canada), Audi Hungária, SAP, Siemens, Mercedes and AIG (New York).
The company was established with the aim of manufacturing and distributing structured material (a flexible textile used primarily in design). The structure and products made of it have been presented at several Hungarian and international fairs, winning a number of awards and recognitions.
Real Balance California
Real Balance California develops innovative products and creates business opportunities in the global market - in 2016, they will launch their first product line of premium dietary supplement drinks. With a unique combination of online shopping and direct sales, the brand will achieve effective distribution and provide a highly competitive business opportunity.
April 2014, Hosszúhetény
Humeltis Biotechnology Research Ltd seeks to use 3D models of lung tissue - a technology developed and patented by company founder Dr. Judit Pongrácz – for pharmaceutical research and personalized medicine. Services provided by the company include testing molecules and other substances for efficacy and toxicology.
The company provides CAD/CAM system services to dental laboratories for zirconia restorations using software developed by the company.
October 2010, Pécs
With its headquarters in Pécs, Számlaközpont Ltd. (Invoice Centre Ltd.) was established in the spring of 2010. The company’s mission is to enable its clients to change over to electronic-based document handling as much as possible, to avoid unnecessary use of paper. The company provides complex electronic invoicing (incoming and outgoing), archiving, and related IT services to its clients.
Velgene Biotechnológiai Kutató Kft.
June 2011, Szeged
Velgene Biotechnology develops small molecules to treat neurodegenerative diseases (Parkinson's disease and Huntington's disease) and cancer. The compounds stimulate the autophagic pathway and so can enhance the the 'self-cleaning' mechanisms of cells in elderly patients to remove cytotoxic proteins.